Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer

SIMPLE SUMMARY: Identifying which men at the time of prostate cancer diagnosis have, or will progress to, an aggressive fatal disease will allow clinicians to assist men in making better informed treatment decisions. This will not only be important for those men whose disease is likely to remain ind...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Nguyen-Dumont, Tú, Dowty, James G., MacInnis, Robert J., Steen, Jason A., Riaz, Moeen, Dugué, Pierre-Antoine, Renault, Anne-Laure, Hammet, Fleur, Mahmoodi, Maryam, Theys, Derrick, Tsimiklis, Helen, Severi, Gianluca, Bolton, Damien, Lacaze, Paul, Sebra, Robert, Schadt, Eric, McNeil, John, Giles, Graham G., Milne, Roger L., Southey, Melissa C.
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8036662/
https://ncbi.nlm.nih.gov/pubmed/33804961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071495
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars